Document Type : Research Paper


Agricultural Science Engineering, Department of Horticultural Sciences, Faculty of Agriculture and Natural Resources, University of Mohaghegh Ardabili, Ardabil, Iran.


Global interest in edible herbs for health care and health promotion has increased significantly in recent years. Ganoderma lucidum is a forest fungus with a woody texture that has been used since ancient times to enhance health and prevent and treat many diseases due to its wide range of secondary metabolites with abundant medicinal properties. So far, many cellular mechanisms have been proposed to explain how the active metabolites function and the health and hygienic properties of this valuable medicinal fungus, including anti-cancer, anti-viral, anti-bacterial, enhanced cellular immunity, antioxidant and many more. This article reviews the scientific findings of scientists on the antimicrobial properties of the medicinal fungus Ganoderma lucidum.


  1. References


    1. Akbar R, Yam WK. Interaction of ganoderic acid on HIV related target: molecular docking studies. Bioinformation. 2011;7: 413.
    2. Batra P, Sharma AK, Khajuria R. Probing Lingzhi or Reishi medicinal mushroom Ganoderma lucidum (higher Basidiomycetes): a bitter mushroom with amazing health benefits. Inter J Med Mushrooms. 2013; 15:127-143.
    3. Cai Q, Li Y, Pei G. Polysaccharides from Ganoderma lucidum attenuate microglia-mediated neuroinflammation and modulate microglial phagocytosis and behavioural response. J Neuroinflammation. 2017; 14: 63.
    4. Chiu HF, Fu HY, Lu YY, Han YC, Shen YC, Venkatakrishnan K, Golovinskaia O, Wang CK. Triterpenoids and polysaccharide peptides-enriched Ganoderma lucidum: a randomized, double-blind placebo-controlled crossover study of its antioxidation and hepatoprotective efficacy in healthy volunteers. Pharmaceutical Biology. 2017; 55: 1041-1046.
    5. Choengpanya K, Ratanabunyong S, Seetaha S, Tabtimmai L, Choowongkomon K. Anti-HIV-1 reverse transcriptase property of some edible mushrooms in Asia. Saudi J Biological Sci. 2021; 28(5): 2807–2815.
    6. Copot O, Tanase C. Maxent modelling of the potential distribution of ganoderma lucidum in north-eastern region of Romania. J Plant Develop. 2017; 24: 133-143.
      Dulger B, Gonuz A. Antimicrobial activity of certain plants used in Turkish traditional medicine. Asian J Plant Sci. 2004; 3 (1):104–107.
    7. Elhassaneen YA, Ragab SS, Salman MS. The Potential Effects of Reishi Mushroom (Ganoderma lucidum) Consumption on Bone Health Indices and Serum Minerals Profile Disorders Induced by CCl4 on Rats. Pyrex J Medic Plant Res. 2016; 2(1):001-007.
    8. Eo SK, Kim YS, Lee CK, Han SS. Antiviral activities of various water and methanol soluble substances isolated from Ganoderma lucidum. J Ethnopharmacology. 1999; 68(1-3): 129-136.
    9. Ferreira IC, Heleno SA, Reis FS, Stojkovic D, Queiroz MJR, Vasconcelos MH, Sokovic M. Chemical features of Ganoderma polysaccharides with antioxidant, antitumor and antimicrobial activities. Phytochemistry. 2015; 114 (1) 38–55.
    10. Flórez-Sampedro L, Zapata W, Orozco LP, Mejía A I, Arboleda C, Rugeles MT. In vitro anti-HIV-1 activity of the enzymatic extract enriched with laccase produced by the fungi Ganoderma sp. and lentinus sp. 2016; 23(2): 109–118.
    11. Fujita R, Liu J, Shimizu K, Konishi F, Noda K, Kumamoto S, Ueda C, Tajiri H, Kaneko S, Suimi Y. Anti-androgenic activities of Ganoderma lucidum. J Ethnopharmacol. 2005; 102 (1):107–112.
    12. Gao Y, Zhou S, Huang M, Xu A. Antibacterial and antiviral value of the genus Ganoderma P. Karst. species (Aphyllophoromycetideae). Inter J Med Mushrooms. 2003; 5(3): 235-246.
    13. Gao YH, Sai XH, Chen GL, Ye JX, Zhou SF. A randomized, placebo-controlled, multi-center study of Ganoderma lucidum (W. Curt.: Fr.) Lloyd (Aphyllophoromycetideae) polysaccharides (Ganopoly) in patients with advanced lung cancer. International J Medic Mushrooms. 2003; 5(4):369-382.
    14. Gaylan CM, Estebal GC, Tantengco OAG, Ragragio EM, Tantengco EM. AntiStaphylococcal and Antioxidant Properties of Crude Ethanolic Extracts of Macrofungi Collected from the Philippines. Pharmacognosy J. 2018;10(1):106-109.
    15. Geng P, Siu KC, Wang Z, Wu JY. Antifatigue functions and mechanisms of edible and medicinal mushrooms. Bio Med Research International. 2017 ;5(3):1-16.
    16. Gill BS, Kumar S. Evaluating anti-oxidant potential of ganoderic acid A in STAT 3 pathway in prostate cancer. Mol Biol Rep. 2016; 43 (12): 1411–1422.
    17. Gill BS, Sharma P, Kumar R, Kumar S. Misconstrued versatility of Ganoderma lucidum: a key player in multi-targeted cellular signaling. Tumor Biology. 2016; 37(3): 2789–2804.
    18. Gurovic MSV, Viceconte FR, Pereyra MT, Bidegain MA, Cubitto MA. DNA damaging potential of Ganoderma lucidum extracts. J Ethnopharmacology. 2018;2 (17): 83–88.
    19. Heleno SA, Ferreira IC, Esteves AP, Ćirić A, Glamočlija J, Martins A, Soković,MM Queiroz MJR. Antimicrobial and demelanizing activity of Ganoderma lucidum extract, phydroxybenzoic and cinnamic acids and their synthetic acetylated glucuronide methyl esters. Food Chem Toxicology. 2013; 58(1):95-100.
    20. Ishimoto Y, Ishibashi KI, Yamanaka D, Adachi Y, Ito H, Igami K, Miyazaki T, Ohno N. Enhanced release of immunostimulating β-1, 3-Glucan by autodigestion of the lingzhi medicinal mushroom, Ganoderma lingzhi (Agaricomycetes). Int J Med Mushrooms. 2017; 19 (1):1-16.
    21. Ji Z, Tang Q, Zhang J, Yang Y, Jia W, Pan Y. Immunomodulation of RAW264. 7 macrophages by GLIS, a proteopolysaccharide from Ganoderma lucidum. J Ethnopharmacol. 2007; 112 (3): 445–450.
    22. Kamble R, Venkata S, Gupta AM. Antimicrobial activity of Ganoderma lucidum mycelium. J Pure Appl Micro. 2011; (5): 983-986.
    23. Kang D, Mutakin M, Levita J. Computational Study of Triterpenoids of Ganoderma lucidum with Aspartic Protease Enzymes for Discovering HIV-1 and Plasmepsin Inhibitors. International J Chem. 2015; 7(1) 62-63.
    24. Kartikeyan S, Bharmal RN, Tiwari RP, Bisen PS. HIV and AIDS: Basic Elements and Priorities. Springer Verlag: Dordrecht, The Netherlands. 2007.
    25. Kim DW, Sovak MA, Zanieski G, Nonet G, Romieu-Mourez RL, Lau AW, Hafer LG, Yaswen P, Stampfer M, Rogers AE. Activation of NF-κB/Rel occurs early during neoplastic transformation of mammary cells. Carcinogenesis 2000; 21 (5): 871–879.
    26. Kim MJ, Kim HW, Lee YS, Shim MJ, Choi EC, Kim BK. Studies on safety of Ganoderma lucidum. Korean J Mycol. 1986; 14 (1): 49-59.
    27. Krishna KV, Karuppuraj V, Perumal K. Antioxidant activity and Folic acid content in indigenous isolates of Ganoderma lucidum. Asian J Pharm Anal 2016; 6 (4): 213–215.
    28. Lakshmi B, Ajith T, Jose N, Janardhanan K. Antimutagenic activity of methanolic extract of Ganoderma lucidum and its effect on hepatic damage caused by benzo [a] pyrene. J Ethnopharmacol. 2006; 107 (2): 297–303.
    29. Lee YH1, Kim JH, et al. Ethanol Extract of Ganoderma lucidum Augments Cellular Anti-oxidant Defense through Activation of Nrf2/HO-1. J Pharmacopuncture. 2016; 19(1):59-69.
    30. Li C, Yin J, Guo F, Zhang D, Sun HH. Ganoderic acid Sz, a new lanostanoid from the mushroom Ganoderma lucidum. Nat. Prod. Res. 2005; 19 (5): 461–465.
    31. Li YQ, Wang SF. Antihepatitis B activities of ganoderic acid from Ganoderma lucidum. Biotechnol Lett. 2006; 28(11):837–41
    32. Liang C, Li Y, Xu J. Enhanced biosynthetic gene expressions and production of ganoderic acids in static liquid culture of Ganoderma lucidum Enhanced biosynthetic gene expressions and production of ganoderic acids in static liquid culture of Ganoderma lucidum under phenoba. Applied Microbiology Biotechnology. 2010; 86(5): 1367–1374.
    33. Lindequist U, Niedermeyer TH, Jülich WD. The pharmacological potential of mushrooms. Evidence-Based Complementary Alternative Medicine. 2005; 2(3):285-299.
    34. Liu J, Yang F, Ye LB, Yang XJ, Timani KA, Zheng Y, Wang YH. Possible mode of action of antiherpetic activities of a proteoglycan isolated from the mycelia of Ganoderma lucidum in vitro. J Ethnopharmacol. 2004; 95 (2–3):265–272.
    35. Ma HT, Hsieh JF, Chen ST. Anti-diabetic effects of Ganoderma lucidum. Phytochemistry. 2015; 114 (1) 109–113.
    36. Matsushita S, Kimura T. Advance in treatment strat- egy and immune reconstruction against HIV1 infection. Microbiol Immunol. 2002; 46(4): 231-239.
    37. McKenna DJ, Jones K, Hughes K. Reishi Botanical Medicines: The Desk reference for Major Herbal Supplements, 2nd ed. The Haworth Herbal Press: New York, Oxford 2002; 825-855.
    38. Mekkawy S, et al. Anti-HIV-1 and anti-HIV-1-protease substances from Ganoderma lucidum. Phytochemistry. 1998; 49(6):1651-1657.
    39. Min BS, Nakamura N, Miyashiro H, BAE KW, Hattori M. Triterpenes from the spores of Ganoderma lucidum and their inhibitory activity against HIV-1 protease. Chem Pharmaceutical Bulletin. 1999; 46(10):1607-1612
    40. Mothana RA, Jansen R, Jülich WD, Lindequist U. Ganomycins A and B, new antimicrobial farnesyl hydroquinones from the basidiomycete Ganoderma pfeifferi. J Nat Prod. 2000; 63 (3): 416–418.
    41. Naveenkumar C, Swathi S, Jayalakshmi G, Chidambaram R, Srikumar R. Screening of antifungal activity of Ganoderma Lucidum extract against medically important Fungi. Indian J Public Health Res. 2018; 9 (1): 269–272.
    42. Nayak A, Nayak RN, Bhat K. Antifungal activity of a toothpaste containing Ganoderma lucidum against Candida albicans-an in vitro study. J Int Oral Health 2010; 2 (2): 51–57.
    43. Oh KW, Lee CK, Kim YS, Eo SK, Han SS. Antiherpetic activities of acidic protein bound polysacchride isolated from Ganoderma lucidum alone and in combinations with acyclovir and vidarabine. J Ethnopharmacol. 2000; 72 (1–2):221–227.
    44. Pan X, Lopez-Olivo MA, Song J, Pratt G, Suarez-Almazor ME. Systematic review of the methodological quality of controlled trials evaluating Chinese herbal medicine in patients with rheumatoid arthritis. BMJ Open. 2017; 7 (3): 013-242.
    45. Paterson R.R.M. Ganoderma A therapeutic fungal biofactory. Phytochemistry. 2006; 67(18): 1985–2001.
    46. Paydary K, et al. The Emergence of Drug Resistant HIV Variants and Novel Anti-Retroviral Therapy. Asian Pacific J Tropical Biomedicine. 2013; (3): 515-522.
    47. Quereshi S, Pandey A, Sandhu S. Evaluation of Antibacterial Activity of Different Ganoderma Lucidum Extracts. Biology. 2010.
    48. Rajasekaran M, Kalaimagal C. Cardioprotective effect of a medicinal mushroom, Ganoderma lucidum against adriamycin induced toxicity. Int J Pharmacol. 2012; 8 (4): 252–258.
    49. Ren A, Qin L, Shi L, Dong X, Mu DS, Li YX, Zhao MW. Methyl jasmonate induces ganoderic acid biosynthesis in the basidiomycetous fungus Ganoderma lucidum. Bioresource Technol. 2010; 101(17): 6785–6790.
    50. Rezghi Jahromi MH. An Introduction to Ganoderma Lucidum, Diabetes and Obesity. 2nd.International Congress on Science and Engineering Hamburg – Germany. 2019.
    51. Sahar EM, Meselhy RM, Norio N, Yasuhiro T, Masao H, Nobuko K, Kunitada S, Takuya K, Toru O. Anti- HIV-1 and Anti-HIV-1-protease substances from Ganoderma lu- cidum. Phytochemistry. 1997; 49(6): 1651-1657.
    52. Sakthivigneswari G, Dharmaraj K. Studies on analysis of few secondary metabolites and antimicrobial activity of Ganoderma lucidum. J Pharm Res. 2013; 1 (8): 781-786.
    53. Sanodiya B, Thakur G, Baghel R, Prasad G, Bisen P. Ganoderma lucidum: A Potent Pharmacological Macrofungus. Current Pharmaceutical Biotechnology. 2009; 10(8): 717–742.
    54. Sarnthima R, Khammaung S, Sa-ard P. Culture broth of Ganoderma lucidum exhibited antioxidant, antibacterial and α-amylase inhibitory activities. J Food Sci Technol. 2017; 54 (11): 3724–3730.
    55. Seo DJ, Choi C. Antiviral bioactive compounds of mushrooms and their antiviral mechanisms. Viruses. 2021; 13(2): 1–12.
    56. Shah P, Modi HA, Shukla MD, Lahiri SK. Preliminary phytochemical analysis and antibacterial activity of Ganoderma lucidum collected from Dang District of Gujarat. India Int J Curr Micro. 2014; 3(3):246-255.
    57. Sharma C, Bhardwaj N, Sharma A, Tuli HS, Batra P, Beniwal V, Gupta GK, Sharma AK. Bioactive metabolites of Ganoderma lucidum: Factors, mechanism and broad spectrum therapeutic potential. J Herbal Med. 2019; 17–18 (8): 100268.
    58. Sheena N, Ajith TA, Janardhanan KK. Prevention of nephrotoxicity induced by the anticancer drug cisplatin, using Ganoderma lucidum, a medicinal mushroom occurring in South India. Current sci. 2003; 85(4): 478-482.
    59. Sheena N, Lakshmi B, Janardhanan KK. Therapeutic potential of Ganoderma lucidum (Fr.) P Karst. Nat Prod Rad. 2005; 4(5): 382-386.
    60. Singh J, Gupta S, Malviya S, Ahrwar B. In-vitro evaluation of antimicrobial activity of Ganoderma lucidum. International J Advanced Research. 2014; 2(1): 460-466.
    61. Siwulski M, Sobieralski K, Golak-Siwulska I, Sokół S, Sękara A. Ganoderma lucidum (Curt.: Fr.) Karst–health-promoting properties. Herba Pol. 2015; 61 (3): 105–118.
    62. Smania EDFA, Delle Monache F, Yunes RA, Paulert R, Smania Junior A. Antimicrobial activity of methyl australate from Ganoderma australe. Rev Bras Farmacogn. 2007; 17 (1): 14–16.
    63. Suay I, Arenal F, Asensio FJ, Basilio A, Cabello MA, Díez MT, García JB, Del Val AG, Gorrochategui J, Hernández P. Screening of basidiomycetes for antimicrobial activities. Antonie Van Leeuwenhoek. 2000; 78 (2):129–140.
    64. Sudheer S, Yeoh WK, Manickam S, Ali A. Effect of ozone gas as an elicitor to enhance the bioactive compounds in Ganoderma lucidum. Postharvest Biology Technol. 2016; 117(1): 81–88.
    65. Vermani K, Garg S. Herbal medicines for sexually transmitted diseases and AIDS. J Ethnopharmacol. 2000; 80() 49-66.
    66. Wachtel Galor S, Szeto YT, Tomlinson B, Benzie FI F. Ganoderma lucidum (Lingzhi): Acute and shortterm biomarker response to supplementation. Inter J Food Sci Nutr. 2004; 55(1):75-83.
    67. Wachtel-Galor S, Yuen J, Buswell JA, Benzie IF. Ganoderma Lucidum (Lingzhi or Reishi). Herbal Medicine: Biomolecular and Clinical Aspects. 2011.
    68. Wang Y, Zhang L, Li Y, Hou X, Zeng F. Correlation of structure to antitumor activities of five derivatives of a β-glucan from Poria cocos sclerotium. Carbohydr Res. 2004; 339 (15): 2567–2574.
    69. Wasser SP, P Weis AL. Therapeutic effects of substances occurring in higher Basidiomycetes mushrooms: a modern perspective. Crit Rev Immunol. 1999; 19 (1):65-96.
    70. Weng Y, Lu J, Xiang L, et al. Ganodermasides C and D, two new anti-aging ergosterols from spores of the medicinal mushroom Ganoderma lucidum. Biosci Biotechnol Biochem. 2011; 75(4): 800-3.
    71. Weng Y, Xiang L, Matsuura A, Zhang Y, Huang Q, Qi J. Ganodermasides A and B, two novel anti-aging ergosterols from spores of a medicinal mushroom Ganoderma lucidum on yeast via UTH1 gene.Bioorg Med Chem. 2010; 18(3):999-1002.
    72. Xu JW, Zhao W, Zhong JJ. Biotechnological production and application of ganoderic acids. Applied Microbiology Biotechnology. 2010; 87(2): 457–466.
    73. You B, Lee M, Tien N, Lee M, Hsieh H, Tseng L, Chung L, Lee H. A Novel Approach to Enhancing Ganoderic Acid Production by Ganoderma lucidum Using Apoptosis Induction. PLoS One. 2013; 8(1): 2–8.
    74. Zeng P, Guo Z, Zeng X, Hao C, Zhang Y, Zhang M, Liu Y, Li H, Li J, Zhang L. Chemical, biochemical, preclinical and clinical studies of Ganoderma lucidum polysaccharide as an approved drug for treating myopathy and other diseases in China. J Cell Mol Med. 2018; (22): 3278-3297.
    75. Zhang XQ, et al. Triterpenoids with Neurotrophic Activity from Ganoderma lucidum. Natural Product Research. 2011; 25(17): 1607-1613.
    76. Zhao C, Zhang C, Xing Z, Ahmad Z, Li JS, Chang M W. Pharmacological effects of natural Ganoderma and its extracts on neurological diseases: A comprehensive review. International J Biol Macromolecules. 2019; 121(1): 1160–1178
    77. Zheng DS, et al. Triterpenoids from Ganoderma lucidum inhibit the activation of EBV antigens as telomerase inhibitors. Exp Ther Med. 2017;14(4):3273-3278.
    78. Zhong JJ, Xiao JH. Secondary metabolites from higher fungi: discovery, bioactivity, and bioproduction. In Biotechnology. 2009; 113 (1): 79-150.
    79. Zhou S, et al. Triterpenes and Soluble Polysaccharide Changes in Lingzhi or Reishi Medicinal Mushroom, Ganoderma lucidum (Agaricomycetes), During Fruiting Growth. Inter J Med Mushrooms. 2018; 20(9):859-871.
    80. Zolj S, Smith MP, Goines JC, T.Shura SA, Huff MO, Robinson DL, Lau JM. Antiproliferative effects of a triterpene-enriched extract from lingzhi or reishi medicinal mushroom, Ganoderma lucidum (agaricomycetes), on human lung cancer cells. Inter J Med Mushrooms. 2018; 20 (12): 1173-1183.